Vetmedin 0.75 mg/ml solution for injection for dogs.
A clear, colourless solution for injection. Each ml contains 0.75mg pimobendan.
To initiate treatment of canine congestive heart failure originating from valvular insufficiency (mitral and/or tricuspid regurgitation) or dilated cardiomyopathy.
Dosage and administration
Single intravenous injection at a dosage of 0.15 mg pimobendan/kg body weight (i.e. 2 ml/10 kg body weight). A 5 ml and a 10 ml vial can treat up to a 25 kg and 50 kg body weight dog respectively. Each vial is for single use only. Vetmedin flavour tablets or Vetmedin hard capsules for dogs may be used for continuation of treatment at the recommended dosage, to be started 12 hours after administration of the injection.
Contra-indications, warnings, etc
The product should not be used in cases of hypertrophic cardiomyopathies or clinical conditions where an augmentation of cardiac output is not possible for functional or anatomical reasons (e.g. aortic stenosis).
In the event of accidental subcutaneous injection, temporary swelling and mild resorptive inflammatory reactions may occur at or below the injection site. For single administration only.
A moderate positive chronotropic effect and vomiting may occur in rare cases.
In rare cases transient diarrhoea, anorexia or lethargy have been observed.
In studies with rats and rabbits pimobendan had no effect on fertility. Embryotoxic effects only occurred at maternotoxic doses. In rat experiments it has been shown that pimobendan is excreted into milk. Therefore, the product should only be administered to pregnant and lactating bitches if the expected therapeutic benefits outweigh the potential risk.
In the case of overdose symptomatic treatment should be initiated.
In the absence of compatibility studies, this veterinary medicinal product must not be mixed with other veterinary medicinal products.
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician.
This product does not contain an antimicrobial preservative. This product is intended for single use only. Any product remaining in the bottle after withdrawal of the required dose should be discarded. Shelf-life of the veterinary medicinal product as packaged for sale: 36 months. Use immediately after opening.
Single-use 5 ml or 10 ml colourless injection glass vial with a rubber stopper and sealed with an aluminium cap, packed singly in a cardboard box. Not all pack sizes may be marketed.